Subscribe To
I3 verticals announces earnings release and conference call dates for first quarter of fiscal 2022
NASHVILLE, Tenn.--(BUSINESS WIRE)--i3 Verticals, Inc. (Nasdaq: IIIV) (“i3 Verticals” or the “Company”), announced today that it will release i...
January 25, 2022, 11:00 am
I3 verticals announces earnings release and conference call dates for first quarter of fiscal 2022
NASHVILLE, Tenn.--(BUSINESS WIRE)--i3 Verticals, Inc. (Nasdaq: IIIV) (“i3 Verticals” or the “Company”), announced today that it will release i...
January 25, 2022, 11:00 am
I3 verticals announces earnings release and conference call dates for first quarter of fiscal 2022
NASHVILLE, Tenn.--(BUSINESS WIRE)--i3 Verticals, Inc. (Nasdaq: IIIV) (“i3 Verticals” or the “Company”), announced today that it will release i...
January 25, 2022, 11:00 am
Shareholder alert: ademi llp investigates whether adamas pharmaceuticals, inc. has obtained a fair price in its transaction with supernus
MILWAUKEE, Oct. 11, 2021 /PRNewswire/ -- Ademi LLP is investigating Adamas (Nasdaq: ADMS), for possible breaches of fiduciary duty and other violatio...
October 11, 2021, 1:37 pm
Shareholder alert: ademi llp investigates whether adamas pharmaceuticals, inc. has obtained a fair price in its transaction with supernus
MILWAUKEE, Oct. 11, 2021 /PRNewswire/ -- Ademi LLP is investigating Adamas (Nasdaq: ADMS), for possible breaches of fiduciary duty and other violatio...
October 11, 2021, 1:37 pm
Shareholder alert: ademi llp investigates whether adamas pharmaceuticals, inc. has obtained a fair price in its transaction with supernus
MILWAUKEE, Oct. 11, 2021 /PRNewswire/ -- Ademi LLP is investigating Adamas (Nasdaq: ADMS), for possible breaches of fiduciary duty and other violatio...
October 11, 2021, 1:37 pm